Lazerhead Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.25 M
- Company Age 46 Year, 26 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.39 M
- Satisfied Charges ₹ 1.30 Cr
- Revenue Growth 4.60%
- Profit Growth 65.38%
- Ebitda 15.78%
- Net Worth 33.73%
- Total Assets 27.88%
About Lazerhead Pharma
Lazerhead Pharma Limited (LPL) is a Public Limited Indian Non-Government Company incorporated in India on 19 January 1979 and has a history of 46 years. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Macmohan Pharma Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.25 M.
The company currently has active open charges totaling ₹3.39 M. The company has closed loans amounting to ₹1.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ramamohan Yelamanchi, Yelamanchi Rao, and Anil Yelamanchi serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24230TG1979PLC072986
-
Company No.
072986
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
19 Jan 1979
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Lazerhead Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Yelamanchi
|
Managing Director | 01-Jul-1996 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Ramamohan Yelamanchi
|
Director | 14-Aug-1979 | Current |
|
Yelamanchi Rao
|
Director | 30-Sep-2015 | Current |
Financial Performance of Lazerhead Pharma.
Lazerhead Pharma Limited, for the financial year ended 2018, experienced modest growth in revenue, with a 4.6% increase. The company also saw a substantial improvement in profitability, with a 65.38% increase in profit. The company's net worth Soared by an impressive increase of 33.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lazerhead Pharma?
In 2018, Lazerhead Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Lazerhead Lifesciences Private LimitedYelamanchi Rao is a mutual person
Charges (Loans)
₹3.39 M
₹13.00 M
Charges Breakdown by Lending Institutions
- A P State Financial Corporation : 0.29 Cr
- State Bank Of India : 0.05 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Sep 1992 | A P State Financial Corporation | ₹2.51 M | Open |
| 09 Jan 1981 | State Bank Of India | ₹0.48 M | Open |
| 21 Dec 1979 | A P State Financial Corporation | ₹0.40 M | Open |
| 24 Feb 2011 | Axis Bank Limited | ₹3.00 M | Satisfied |
| 31 Mar 2008 | Axis Bank Limited | ₹1.00 Cr | Satisfied |
How Many Employees Work at Lazerhead Pharma?
Lazerhead Pharma has a workforce of 4 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lazerhead Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lazerhead Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
